Glenmark’s Q4FY26 profit surged to ₹301.4 crore, marking a rise of over 6,400% from ₹4.6 crore a year earlier. Shares of Glenmark Pharmaceuticals Ltd ended at ₹2,274.25, down by ₹108.40, or 4.55%, on the BSE today, May 30.
Glenmark’s Q4FY26 profit surged to ₹301.4 crore, marking a rise of over 6,400% from ₹4.6 crore a year earlier. Shares of Glenmark Pharmaceuticals Ltd ended at ₹2,274.25, down by ₹108.40, or 4.55%, on the BSE today, May 30.